<DOC>
	<DOCNO>NCT00416559</DOCNO>
	<brief_summary>RATIONALE : Observation closely monitor patient 's condition give treatment symptom appear change . Observation may help doctor see effective surgery treat neuroblastoma . PURPOSE : This phase II trial study well surgery alone work treat young patient localized neuroblastoma .</brief_summary>
	<brief_title>Observation Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate safety efficacy surgical treatment alone young patient stage 2 neuroblastoma without N-myc amplification ( NMA ) . Secondary - Determine predictive factor relapse survival patient stage 1 , 2A , 2B neuroblastoma without NMA undergone surgery . OUTLINE : This nonrandomized , multicenter study . Patients stage 1 2 disease N-myc amplification ( NMA ) undergo observation comprise clinical evaluation , ultrasound CT scan abdomen , chest x-ray periodically 5 year . All patient undergo additional therapy follow-up accord national standard . Patients develop recurrent disease disease progression may undergo surgical resection , precede follow chemotherapy , accord national standard . PROJECTED ACCRUAL : A total 140 patient accrue study .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm neuroblastoma ganglioneuroblastoma Meets 1 follow International Neuroblastoma Staging System ( INSS ) criterion : Stage 1 Stage 2A 2B meeting 1 follow criterion : With without Nmyc amplification No evaluation NMA Symptomatic spinal cord compression Stage 3* Dumbbell syndrome clinical sign spinal cord compression* NOTE : *These patient eligible study undergo observation ; instead undergo standard treatment Has undergone complete gross surgical resection OR diagnostic surgical needle biopsy No metastasis within 1 month diagnosis No skin metastases clinical examination MIBG scan Normal liver CT scan ultrasonography Normal chest Xray ( case nonthoracic primary site ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics Prior steroid allow No prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
</DOC>